deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02911285

NAC for Treating Comorbid PTSD and SUD (DoD-NAC)

Glial Regulators for Treating Comorbid Posttraumatic Stress Disorder and Substance Use Disorders

Sponsor: Institute for Translational Neuroscience

Conditions Alcohol Use Disorder (AUD) Posttraumatic Stress Disorder (PTSD) Substance Use Disorder (SUD)
Interventions Cognitive behavioral therapy N-acetylcysteine Placebo
Updated 14 times since 2017 Last updated: Apr 28, 2021 Started: Oct 31, 2016 Primary completion: Aug 5, 2019 Completion: Nov 4, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD), this trial is completed. The trial is conducted by Institute for Translational Neuroscience and has accumulated 14 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshot~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Aug 2019 · 9 months · monthly snapshot~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshot~Dec 2019 – ~Feb 2020 · 2 months · monthly snapshot~Feb 2020 – ~Jul 2020 · 5 months · monthly snapshot~Jul 2020 – ~Dec 2020 · 5 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Jul 2024 · 37 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jun 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jun 2021 [monthly]

    Completed PHASE2

  5. Dec 2020 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 9 earlier versions

  1. Jul 2020 — Dec 2020 [monthly]

    Completed PHASE2

  2. Feb 2020 — Jul 2020 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

  3. Dec 2019 — Feb 2020 [monthly]

    Active Not Recruiting PHASE2

  4. Aug 2019 — Dec 2019 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  5. Nov 2018 — Aug 2019 [monthly]

    Recruiting PHASE2

  6. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  7. Oct 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  8. Feb 2017 — Oct 2017 [monthly]

    Recruiting PHASE2

  9. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institute for Translational Neuroscience
  • Medical University of South Carolina
  • United States Department of Defense
Data source: Medical University of South Carolina

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations